Live feed
Filing
SC 13G
SC 13G0001535610-20-000124·REVIVA PHARMACEUTICALS HOLDINGS, INC.
Schedule 13G ownership disclosure
REVIVA PHARMACEUTCLS HLDGS INC COM
Security class unavailable · CUSIP: G8708A116
Event date: 2020-12-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 502,194
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000124
- Form type
- SC 13G
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Dec 18, 2020
- Reporting period
- Dec 08, 2020
- Description
- Schedule 13G beneficial ownership